Nils Rudqvist, Director and Scientific Strategic Program Manager at Agenus, shared a post on LinkedIn:

“Excited to fully support Sandra Demaria as she is running to become the next Society for Immunotherapy of Cancer (SITC) vice president! Her dedication to cancer patients as a translational scientist is truly inspiring, she does not shy away from challenges and leads with compassion, evident from her many successful mentees and leadership roles.

I am thrilled about the prospect of Sandra bringing her energy and expertise to SITC’s vice president role, just as she has consistently supported the society in numerous other roles before. She is a true powerhouse, and I can’t wait to see the positive impact she will make!”

Additional information
Source: Nils Rudqvist/LinkedIn